$958.18 Nov 18, 2026 · market cap $104B
Regeneron Pharmaceuticals trades at $958. Our three models put it at $789–$1,615 (base $994): 4% below the base.
Damodaran $1,615 · Buffett $994 · Cash Flow $789 · models run Nov 18, 2026
14 of 121 tracked investors hold it · Q3 2026 13F filings
Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app